Uecker Darrin's Form 4 filing
Pulse Biosciences, Inc. (PLSE) · filed Jun 16, 2025
- Accession no.
- 0001437749-25-020563
- Filed
- Jun 16, 2025
- Trade date
- Jun 12-13, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $485.7K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Uecker DarrinCIK 0001276311 | Director, Officer (Chief Technology Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 12, 2025 | Common Stock | SSaleDisposed | −15,000 | $16.40 | −$246,000 | 137,872 | Direct | |
| Jun 13, 2025 | Common Stock | SSaleDisposed | −15,000 | $15.98 | −$239,700 | 122,872 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.